Effect of n-3 Polyunsaturated Fatty Acids on Induction of Hypoxia Inducible Factor-2 Alpha in C2C12 Myotubes

[1]  Hakuo Takahashi,et al.  Oral Nicorandil for Prevention of Cardiac Death in Hemodialysis Patients without Obstructive Coronary Artery Disease: A Propensity-Matched Patient Analysis , 2011, Nephron Clinical Practice.

[2]  F. Lallemand,et al.  Reduced cardiac remodelling and prevention of glutathione deficiency after omega‐3 supplementation in chronic heart failure , 2011, Fundamental & clinical pharmacology.

[3]  A. El-Sohemy,et al.  Regulation of osteoblast and adipocyte differentiation from human mesenchymal stem cells by conjugated linoleic acid. , 2009, The Journal of nutritional biochemistry.

[4]  J. Napier,et al.  The synthesis and accumulation of stearidonic acid in transgenic plants: a novel source of 'heart-healthy' omega-3 fatty acids. , 2009, Plant biotechnology journal.

[5]  M. Rashid,et al.  Comparison of Hypotensive and Hypolipidemic Effects of Catharanthus roseus Leaves Extract with Nifedipine on Adrenaline Induced Hypertensive Rats , 2008 .

[6]  V. Anand,et al.  Redeeming Measure of Atorvastatin in the Risk Factors of Cardiovascular Disease , 2008 .

[7]  Robert A. Harris,et al.  Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism , 2008, Nature Genetics.

[8]  M. Eftekhari,et al.  Blood lipid and lipoprotein profile of female athletes with respect to their jobs and nutrients intake. , 2008, Pakistan journal of biological sciences : PJBS.

[9]  Zhu Liancai,et al.  Effect of Ginsenosides on Malondialdehyde, Nitric Oxide and Endothelin-1 Production in Vascular Endothelial Cells Suffering from Lipid Peroxidation Injury , 2007 .

[10]  Tetsuhiro Tanaka,et al.  Organ protection by hypoxia and hypoxia-inducible factors. , 2007, Methods in enzymology.

[11]  .. B.A.Jalali-khanabadi,et al.  Association of Cholesterol-rich Lipoproteins with Coronary Artery Disease in Subjects Who Referred to Yazd Cardiovascular Research Center for Coronary Angiography , 2006 .

[12]  M. Uddin,et al.  Prevalence of Dyslipidemic Phenotypes Including Hyper-apoB and Evaluation of Cardiovascular Disease Risk in Normocholesterolemic Type 2 Diabetic Patients , 2006 .

[13]  S. Panagiotopoulos,et al.  Peroxisome proliferator-activated receptor alpha agonist, clofibrate, has profound influence on myocardial fatty acid composition. , 2006, Chemico-biological interactions.

[14]  P. Maxwell.  Hypoxia‐inducible factor as a physiological regulator , 2005, Experimental physiology.

[15]  G. Decorti,et al.  Modulation of MDR1 gene expression by a chronic treatment with verapamil in Caco-2 cells , 2005 .

[16]  Robert A. Harris,et al.  Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. , 2001, Biochemical and biophysical research communications.